Status:
UNKNOWN
SLOW-Slower Progress of caLcificatiOn With Vitamin K2
Lead Sponsor:
National and Kapodistrian University of Athens
Conditions:
Aortic Valve Stenosis
Aortic Valve Calcification
Eligibility:
All Genders
50+ years
Phase:
NA
Brief Summary
A randomized 12-month trial will include two groups of 100 individuals aged over 50 years, with asymptomatic mild to moderate Aortic valve stenosis (AVA \> 1 cm2, Vmax \< 4 m/s). The first group of 10...
Detailed Description
For the purposes of this study, all individuals will be subjected to the same quantitative and qualitative tests, before and after the daily administration of 300mcg K2 vitamin/placebo for a period of...
Eligibility Criteria
Inclusion
- ASYMPTOMATIC AV STENOSIS WITH AVA\>1 cm2 \& Vmax\<4m/s
Exclusion
- AVK,STATINS,MSCT THE LAST 6 MONTHS,PROSTHETIC VALVES, AVA\<1 cm2,Vmax\>4m/s
Key Trial Info
Start Date :
September 23 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 23 2023
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04429035
Start Date
September 23 2019
End Date
December 23 2023
Last Update
September 1 2021
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
First Department of Cardiology, University of Athens
Athens, Attica, Greece, 11527
2
Hippokration Hospital 1st Department of Cardiology,National and Kapodistrian University of Athens,Medical School
Athens, Attica, Greece, 11527